{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:16:06Z","timestamp":1790046966586,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T00:00:00Z","timestamp":1686009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Surgery"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.asjsur.2023.05.174","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T02:05:31Z","timestamp":1686881131000},"page":"3529-3541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identification of prognostic melatonin-related lncRNA signature in tumor immune microenvironment and drug resistance for breast cancer"],"prefix":"10.1016","volume":"46","author":[{"given":"Shou-Cui","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6965-2774","authenticated-orcid":false,"given":"Chen-Long","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.asjsur.2023.05.174_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA A Cancer J Clin"},{"key":"10.1016\/j.asjsur.2023.05.174_bib2","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/cncr.32648","article-title":"Causes of death after breast cancer diagnosis: a US population-based analysis","volume":"126","author":"Afifi","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.asjsur.2023.05.174_bib3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdy517","article-title":"Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study","volume":"30","author":"Adams","year":"2019","journal-title":"Ann Oncol : Offc J Euro Soc Med Oncol"},{"key":"10.1016\/j.asjsur.2023.05.174_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.critrevonc.2017.12.018","article-title":"Melatonin and breast cancer: evidences from preclinical and human studies","volume":"122","author":"Kubatka","year":"2018","journal-title":"Crit Rev Oncol-Hematol"},{"key":"10.1016\/j.asjsur.2023.05.174_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1534735408322846","article-title":"Therapeutic actions of melatonin in cancer: possible mechanisms","volume":"7","author":"Srinivasan","year":"2008","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.asjsur.2023.05.174_bib6","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00018-003-2319-1","article-title":"Melatonin and cell death: differential actions on apoptosis in normal and cancer cells","volume":"60","author":"Sainz","year":"2003","journal-title":"Cell Mol Life Sci : CMLS"},{"key":"10.1016\/j.asjsur.2023.05.174_bib7","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1530\/ERC-15-0030","article-title":"Melatonin: an inhibitor of breast cancer","volume":"22","author":"Hill","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.asjsur.2023.05.174_bib8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biopha.2012.10.005","article-title":"Melatonin is involved in the apoptosis and necrosis of pancreatic cancer cell line SW-1990 via modulating of Bcl-2\/Bax balance","volume":"67","author":"Xu","year":"2013","journal-title":"Biomed Pharmacotherap\u00a0= Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.asjsur.2023.05.174_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0085311","article-title":"Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer","volume":"9","author":"Jardim-Perassi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.asjsur.2023.05.174_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116960","article-title":"Boosting immune system against cancer by melatonin: a mechanistic viewpoint","volume":"238","author":"Mortezaee","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.asjsur.2023.05.174_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/08916939709009549","article-title":"Melatonin, immune modulation and aging","volume":"26","author":"Zhang","year":"1997","journal-title":"Autoimmunity"},{"key":"10.1016\/j.asjsur.2023.05.174_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-5728(99)00271-4","article-title":"Exogenous melatonin: quantitative enhancement in\u00a0vivo of cells mediating non-specific immunity","volume":"104","author":"Currier","year":"2000","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.asjsur.2023.05.174_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000164122","article-title":"Luzindole, a melatonin receptor antagonist, suppresses experimental autoimmune encephalomyelitis","volume":"65","author":"Constantinescu","year":"1997","journal-title":"Pathobiology : J Immunopathol Mol Cell Biol"},{"key":"10.1016\/j.asjsur.2023.05.174_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding RNAs in the human transcriptome","volume":"47","author":"Iyer","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.asjsur.2023.05.174_bib15","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","article-title":"Long noncoding RNAs in cancer pathways","volume":"29","author":"Schmitt","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.asjsur.2023.05.174_bib16","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08975","article-title":"Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis","volume":"464","author":"Gupta","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.asjsur.2023.05.174_bib17","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41419-021-04006-x","article-title":"Melatonin inhibits triple-negative breast cancer progression through the Lnc049808-FUNDC1 pathway","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.asjsur.2023.05.174_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/jjco\/hyz213","article-title":"Adjuvant and neoadjuvant therapy for breast cancer","volume":"50","author":"Shien","year":"2020","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.asjsur.2023.05.174_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1126\/science.355.6320.35-k","article-title":"A\u00a0very focused function for lncRNAs","volume":"355","author":"Riddihough","year":"2017","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.asjsur.2023.05.174_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/1878-0261.12472","article-title":"Interplay of lncRNA H19\/miR-675 and lncRNA NEAT1\/miR-204 in breast cancer","volume":"13","author":"M\u00fcller","year":"2019","journal-title":"Mol Oncol"},{"key":"10.1016\/j.asjsur.2023.05.174_bib21","first-page":"217","article-title":"LncRNA-encoded polypeptide ASRPS inhibits triple-negative breast cancer angiogenesis","author":"Wang","year":"2020","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.asjsur.2023.05.174_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/cdd.2016.95","article-title":"The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer","volume":"24","author":"Li","year":"2017","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.asjsur.2023.05.174_bib23","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1038\/s41467-020-18735-8","article-title":"c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis","volume":"11","author":"Feng","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.asjsur.2023.05.174_bib24","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.omtn.2021.04.007","article-title":"lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2","volume":"24","author":"Hong","year":"2021","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.asjsur.2023.05.174_bib25","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1158\/0008-5472.CAN-20-3903","article-title":"SCIRT lncRNA blocks the shot of breast cancer cells self-renewal mechanism","volume":"81","author":"Pardini","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.asjsur.2023.05.174_bib26","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1038\/s41467-020-19349-w","article-title":"LncRNA DILA1 inhibits Cyclin D1 degradation and contributes to tamoxifen resistance in breast cancer","volume":"11","author":"Shi","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.asjsur.2023.05.174_bib27","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.omtn.2019.12.019","article-title":"Melatonin regulates breast cancer progression by the lnc010561\/miR-30\/FKBP3 Axis","volume":"19","author":"Liu","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.asjsur.2023.05.174_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12758","article-title":"Pan-cancer analyses reveal genomics and clinical characteristics of the melatonergic regulators in cancer","volume":"71","author":"Zhang","year":"2021","journal-title":"J\u00a0Pineal Res"},{"key":"10.1016\/j.asjsur.2023.05.174_bib29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1139\/bcb-2018-0039","article-title":"Overexpression of MAPT-AS1 is associated with better patient survival in breast cancer","volume":"97","author":"Wang","year":"2019","journal-title":"Biochemistry and cell biology\u00a0= Biochimie et biologie cellulaire"},{"key":"10.1016\/j.asjsur.2023.05.174_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.21037\/atm-22-1956","article-title":"Investigating the potential clinical significance of long non-coding RNA 00092 in patients with breast cancer","volume":"10","author":"Li","year":"2022","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.asjsur.2023.05.174_bib31","first-page":"2572","article-title":"Comprehensive analysis of the lncRNA-associated competing endogenous RNA network in breast cancer","volume":"42","author":"Wang","year":"2019","journal-title":"Oncol Rep"},{"key":"10.1016\/j.asjsur.2023.05.174_bib32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.canlet.2021.06.011","article-title":"Induction of EnR stress by Melatonin enhances the cytotoxic effect of Lapatinib in HER2-positive breast cancer","volume":"518","author":"Sang","year":"2021","journal-title":"Cancer Lett"},{"key":"10.1016\/j.asjsur.2023.05.174_bib33","first-page":"13","article-title":"A\u00a0small-molecule activator of the unfolded protein response eradicates human breast tumors in mice","author":"Boudreau","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.asjsur.2023.05.174_bib34","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1038\/s41467-019-11048-5","article-title":"BRCA2 abrogation triggers innate immune responses potentiated by treatment with PARP inhibitors","volume":"10","author":"Reisl\u00e4nder","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.asjsur.2023.05.174_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejca.2021.12.003","article-title":"Interval breast cancer is associated with interferon immune response","volume":"162","author":"Ugalde-Morales","year":"2022","journal-title":"Euro J Cancer"},{"key":"10.1016\/j.asjsur.2023.05.174_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejca.2019.09.002","article-title":"Metabolic crosstalk in the breast cancer microenvironment","volume":"121","author":"Dias","year":"2019","journal-title":"Euro J Cancer"},{"key":"10.1016\/j.asjsur.2023.05.174_bib37","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41580-021-00447-6","article-title":"Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics","volume":"23","author":"Nojima","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.asjsur.2023.05.174_bib38","article-title":"Research progresses in immunological checkpoint inhibitors for breast cancer immunotherapy","volume":"11","author":"Zhang","year":"2021","journal-title":"Front Oncol"}],"container-title":["Asian Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958423008242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1015958423008242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T17:32:47Z","timestamp":1760895167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1015958423008242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1015958423008242"],"URL":"https:\/\/doi.org\/10.1016\/j.asjsur.2023.05.174","relation":{},"ISSN":["1015-9584"],"issn-type":[{"value":"1015-9584","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of prognostic melatonin-related lncRNA signature in tumor immune microenvironment and drug resistance for breast cancer","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.asjsur.2023.05.174","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Asian Surgical Association and Taiwan Robotic Surgery Association. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}